PlenSat, Inc.

PlenSat is an early stage biomedical device startup pursuing its patented technology for the treatment of obesity. PlenSat ‘Digestible Balloons” are a unique approach to achieving Bariatric effects to treat obesity without invasive techniques such as surgery, laparoscopy or endoscopy. Digestible Balloons, produced from food grade materials, promise the simplicity of pharmaceutical dosage with the weight loss profile of Bariatric techniques.

PlenSat’s technology involves the production of easily ingestible capsules that are self-inflating in the acidic environment within the stomach. The expanded capsule, a “Digestible Balloon”, is sized such that once inflated it will not pass beyond the stomach until time and abrasive wear breaks it down. It is anticipated, based upon our pre-clinical and initial animal studies, that the Digestible Balloon will have a lifetime of between 7 and 30 days within the stomach. The Digestible Balloon is designed to be ultimately digested in the intestine after mechanical breakdown in the stomach.

Company’s Keywords:

healthcare, health & wellness, medical devices, medical, health care, obesity & medical devices